Docmode Health Technologies Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDConsumer Services
Consumer services have a mixed operating backdrop but strong market sponsorship. Foreign tourist arrivals in India rose 6.0% YoY (2026-06), export of services grew 13.0% YoY (2026-06), and headline tourist arrivals were 584000 (Jun/26), though airport passenger traffic was -2.0% YoY (2026-06). Strong FPI inflow of INR 19847 crore over 3 months to 2026-08-31 supports a Buy stance despite some travel softness.
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 20.4%
- Company has delivered good sales growth of 43.2% CAGR over last 5 years
- Working capital cycle has improved - days down from 41 to -37
CONS
- Company is loss-making at the operating / net level
- Interest coverage is weak at -0.0x - earnings barely cover interest
- Operating margins have contracted to -1.6% from 15.3%
- Inventory has been piling up - inventory days up from 23 to 60
- Company's return on assets is weak at -5.9%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| PWL | 126.75 | 1803.72 | 36768.74 | 0.00 | -882.80 | -595.06 | 10539.50 | 1144.20 | 3.69 | -5.41 |
| SEIL | 195.05 | 540.31 | 3140.30 | 0.00 | 2.82 | -2.76 | 16.30 | 7.51 | 10.42 | 26.28 |
| CRIZAC | 179.40 | 14.24 | 3139.19 | 4.46 | 46.17 | 0.77 | 201.21 | -3.97 | 52.73 | 30.40 |
| VERANDA | 231.35 | 15.48 | 2232.68 | 0.00 | 33.87 | 467.88 | 149.54 | 7.37 | 22.75 | 35.96 |
| JARO | 455.90 | 26.73 | 1015.31 | 1.10 | 11.17 | 48.33 | 70.75 | 16.60 | 25.32 | 21.43 |
| GLOBAL | 123.56 | 24.12 | 628.94 | 0.81 | 3.75 | -11.05 | 14.21 | -4.15 | 29.17 | 41.68 |
| CLEDUCATE | 59.51 | 0.00 | 323.10 | 0.00 | -1.67 | 55.01 | 127.51 | -12.47 | 2.03 | 13.62 |
| CPEDU | 176.45 | 13.46 | 321.01 | 1.42 | 8.08 | 12.54 | 14.35 | -1.17 | 46.88 | 64.15 |
| CPCAP | 134.65 | 5.43 | 244.97 | 0.00 | 13.31 | 23.50 | 21.95 | 47.39 | 9.83 | 93.11 |
| TREEHOUSE | 6.00 | 0.00 | 25.39 | 0.00 | -2.13 | -233.00 | 1.15 | -20.14 | -6.84 | -212.70 |
| DHTL | 34.20 | 0.00 | 10.75 | 0.00 | — | — | — | — | -0.27 | — |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 7 | 7 | 12 | 33 | 40 | 42 | |
| 7 | 6 | 11 | 29 | 38 | 42 | |
| Operating Profit | 0 | 1 | 2 | 4 | 2 | -1 |
| OPM % | 5.65% | 12.22% | 15.18% | 11.39% | 4.71% | -1.62% |
| 0 | 0 | 0 | 0 | 0 | 1 | |
| Interest | 0 | 0 | 0 | 1 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before Tax | 0 | 1 | 2 | 3 | 0 | -2 |
| Tax % | -3.33% | 14.10% | 38.55% | 27.60% | 44.77% | -3.11% |
| Net Profit | 0 | 1 | 1 | 2 | 0 | -2 |
| EPS | 0.00 | 0.00 | 5.24 | 8.50 | 0.60 | -6.45 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 43%
- 3 Years:
- 50%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -21%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 91%
- 3 Years:
- 20%
- Last Year:
- -22%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0 | 0 | 0 | 2 | 3 | 3 |
| -0 | 0 | 1 | 1 | 7 | 5 | |
| 0 | 1 | 5 | 6 | 5 | 4 | |
| Trade Payables | 1 | 3 | 2 | 3 | 3 | 5 |
| 1 | 2 | 2 | 5 | 11 | 21 | |
| Total Liabilities | 2 | 6 | 10 | 17 | 30 | 39 |
| 0 | 0 | 0 | 0 | 1 | 1 | |
| 0 | 0 | 1 | 1 | 1 | 1 | |
| 1 | 3 | 3 | 3 | 3 | 11 | |
| 0 | 0 | 0 | 0 | 11 | 9 | |
| Cash & Bank | 0 | 0 | 0 | 0 | 3 | 2 |
| 0 | 2 | 6 | 13 | 11 | 14 | |
| Total Assets | 2 | 6 | 10 | 17 | 30 | 39 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 0 | -0 | -2 | -1 | 5 | 7 | |
| Cash from Investing | -0 | -0 | -2 | -2 | -8 | -4 |
| Cash from Financing | 0 | 1 | 3 | 3 | 6 | -4 |
| -0 | 0 | -0 | 0 | 3 | -1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
No announcements filed.
News
Recent coverage and analyst commentary for DHTL
Loading news…
AI Stock Analyst
Docmode Health Technologies Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account